
[Federal Register Volume 79, Number 126 (Tuesday, July 1, 2014)]
[Notices]
[Pages 37332-37333]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-15374]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0833]


Office of the Commissioner; Request for Comments on the Food and 
Drug Administration Fiscal Year 2014-2018 Strategic Priorities 
Document; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is seeking public 
comments on its draft Strategic Priorities Fiscal Year (FY) 2014-2018 
document. FDA has identified these cross-cutting strategic priorities 
and core mission goals that will guide its efforts to achieve its 
public health mission. FDA is seeking public comment to help further 
refine these priorities and goals.

DATES: Submit either electronic or written comments by July 31, 2014.

ADDRESSES: Submit electronic comments to http://www.regulations.gov. 
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, 
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Darian Tarver, Office of the

[[Page 37333]]

Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 32, Rm. 3238, Silver Spring, MD 20993-0002, 301-796-4850.

SUPPLEMENTARY INFORMATION: 

I. Background

    FDA is posting its draft Strategic Priorities FY 2014-2018 document 
to ensure that the public has an opportunity to comment on this 
document.
    The purpose of this document is to outline FDA's strategic 
intentions and plans for the next 4 years. This document identifies 
five cross-cutting strategic priorities and four core mission goals 
that will guide efforts to achieve FDA's public health mission and to 
fulfill its role in supporting the larger mission and strategic goals 
of the Department of Health and Human Services. The five cross-cutting 
strategic priorities are: (1) Regulatory science, (2) globalization, 
(3) safety and quality, (4) smart regulation, and (5) stewardship. The 
four core mission goals are: (1) Enhance oversight of FDA-regulated 
products, (2) improve and safeguard access to FDA-regulated products to 
benefit health, (3) promote better informed decisions about the use of 
FDA-regulated products, and (4) strengthen organizational excellence 
and accountability.
    For comparison purposes, the current FDA Strategic Priorities FY 
2011-2015 document can be viewed at http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm227527.htm.
    The text of the draft Strategic Priorities FY 2014-2018 document is 
available in a downloadable portable document format through FDA's Web 
site: http://www.fda.gov/AboutFDA/. We look forward to receiving your 
comments (see DATES).

II. Comments

    Interested persons may submit either electronic comments regarding 
this document to http://www.regulations.gov or written comments to the 
Division of Dockets Management (see ADDRESSES). It is only necessary to 
send one set of comments. Identify comments with the docket number 
found in brackets in the heading of this document. Received comments 
may be seen in the Division of Dockets Management between 9 a.m. and 4 
p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.

    Dated: June 26, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-15374 Filed 6-30-14; 8:45 am]
BILLING CODE 4164-01-P


